|
Feasibility and Effectiveness - MAP Online Program - Emerging Adults - Phase II |
|
IVD in colon cancer |
|
Prebiotics and prebiotics in the treatment of type 2 diabetes |
|
Nasal recombinant human interferon alfa-2b in ARI |
|
Jusvinza in Severe Patients with Acquired Community Pneumonia |
|
NeuroEPO in mild-moderate Alzheimer's disease amnesic variant |
|
NeuroEPO in mild-moderate Alzheimer's disease |
|
Sinopharm-SOBERANA COVID-Cienfuegos |
|
Nasalferon in ARI |
|
Effect of dietary fiber consumption on health |
|
Evaluation of Clinical Performance of INFANTIX in a Maternity Hospital |
|
Jusvinza in rheumatoid arthritis |
|
NUTRIRES2 |
|
Post EUA study of Itolizumab in COVID-19 |
|
Antioxidant efcts of Abexol in middle-aged and older subjects |
|
VALIDATION OF AUTOMATIC DEVICES IN THE CLINIC: VALIDAC-1 |
|
Nasalferon in COVID-19 |
|
BACONAO Study |
|
SOBERANA PLUS TURIN |
|
Expanded Clinical Use of Nasalferon in COVID-19 |
